Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab and Tocilizumab Combination in RA
NCT00845832Phase 2Terminated
- Sponsor
- Roche
- Start
- Mar 2009
- Primary completion
- Mar 2013
- Modality
- Monoclonal Antibodies
- Countries
- 8
01
Overview
A Phase 2 trial of rituximab in rheumatoid arthritis (RA), sponsored by Roche. Started Mar 2009; status: terminated.
02
Drugs
rituximab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00845832.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00845832.